Not to the public. It's against the law to publish an advertisement likely to lead to the use of a prescription-only medicine, and botulinum toxin medicines are prescription-only. The ASA treats promotional social media posts, hashtags and indirect terms such as "wrinkle-relaxing injections" as promoting botulinum toxin treatment. A clinic can promote its service and a consultation, as long as the ad doesn't directly or indirectly promote the medicine.
Where you live matters
What counts
ASA enforcement notice
Treated as promoting it
Brand names (Botox, Vistabel, Dysport, Bocouture, Azzalure) and variants such as "Beautox"; #botox; "wrinkle-relaxing injections"; "anti-wrinkle injections" alongside a price; "Botox parties"; and botulinum toxin treatment as a prize or in a deal.
What's allowed
Consultations and price lists
Promote the service
A clinic can promote itself and the consultation, for example "a consultation for the treatment of lines and wrinkles", as long as it doesn't directly or indirectly promote the medicine. A factual price list falls outside the legal definition of advertising only if no product claim is made.
Fillers
Not treated as prescription-only by the ASA
Can be advertised, with care
The ASA accepts ads for dermal fillers that are clearly named as fillers. Their wider legal classification can depend on the product. Filler ads must still follow the other advertising rules, for example on misleading claims, and the ASA warns against pairing "dermal fillers" with "anti-wrinkle injections".
Who enforces
ASA and MHRA
Two regulators
The ASA enforces the advertising codes. The MHRA enforces the medicines regulations.
What the law says
A person may not publish an advertisement that is likely to lead to the use of a prescription only medicine.
In these regulations “advertisement”, in relation to a medicinal product, includes anything designed to promote the prescription, supply, sale or use of that product.